Sutro Biopharma, an immunotherapy developer commercialising technology created at Stanford University, has floated on the Nasdaq Global Market.

UCLA co-led the online meat and fish merchant's series C round, which included Bertelsmann, Sistema Asia and Vertex Ventures.

Satellite launching rocket producer Gilmour Space Technologies has been backed by Main Sequence Ventures, managers of Csiro Innovation Fund, taking its total to $17.4m.

University of Rochester-affiliated VC fund Excell Partners has been selected to manage a state government-funded vehicle targeting local companies in sectors such as optics and life sciences.

SoftBank Vision Fund, which invested $450m in Compass in December, returned to co-lead a series F round that valued it at $4.4bn.

Fosun Pharma has contributed to a $250m series D round for medical device maker Butterfly Network, valuing the company at $1.25bn.

Novo has co-led a series B round together with Omega Funds for Morphic Therapeutic, based on research by Harvard professor Timothy Springer.

Software bug checking developer Code Intelligence spun out of University of Bonn in 2017 and has now been backed by HTGF and Digital Hub Bonn.

Invenergy Future Fund has been rebranded as Energize Ventures and closed a $150m fund that includes GE, Schneider Electric and WEC Energy as LPs.

CUNY-born digital olfaction technology developer MouSensor will receive funding and expertise from nanoelectronics institute Imec's investment fund.